| 125 | 1 | 26 |
| 下载次数 | 被引频次 | 阅读次数 |
目的 通过乳腺癌差异表达长链非编码RNA(lncRNA)的筛选,探讨其在乳腺癌发生、发展中的作用及潜在功能。方法 收集2018年9月—11月新疆医科大学附属肿瘤医院5对女性乳腺癌组织标本及其癌旁正常组织(距肿瘤大于5 cm)标本,通过RNA提取、标记和杂交、芯片实验,以差异倍数(FC)≥2倍,t检验的P值<0.05作为筛选条件,筛选出差异表达的lncRNA。对筛选的lncRNA在正常乳腺组织和乳腺癌癌组织的表达量进行聚类分析。对差异lncRNA基因本体(Gene Ontology,GO)富集和京都基因与基因组百科全书(kyoto encyclopedia of genes and genomes,KEGG)信号通路分析获得lncRNA参与的生物学途径。结果 乳腺癌组织与癌旁组织相比,乳腺癌组织中具有2倍以上的差异表达(|log2FC|>1)lncRNA共有1 150条,其中上调lncRNA 551条,下调lncRNA 599条。下调lncRNA差异最显著的为XR_159043.1(FC=26.878,P<0.05),上调lncRNA差异最为显著的是ENST00000427451.1(FC=11.478,P<0.05)。通过GO富集分析发现,lncRNA广泛参与了包括RNA加工、DNA剪接、基因表达、含核碱基的化合物代谢、核酸转运mRNA剪接等生物学进程。KEGG信号通路富集分析发现,lncRNA参与了PI3K-AKT、RIG-I样受体信号通路,参与了癌症中的转录失调、病毒感染、雌激素信号通路等进程,并测出差异表达lncRNA有119种靶基因。结论 本研究是乳腺癌相关的lncRNA谱的补充,研究发现了一定数量差异表达的lncRNA,并预测其功能靶向基因和途径,有望为乳腺癌的靶向治疗和预后评估提供新的参考依据。
Abstract:Objective To explore the role and the potential function of breast cancer in development of breast cancer by screening long-chain non-coding RNAs of breast cancer. Methods From September to November in 2018, five pairs of female breast cancer tissue specimens and normal tissues adjacent to the cancer(more than 5 cm away from the tumor) were collected and were subjected to RNA extraction, labeling and hybridization, and chip experiments. Differentially expressed on lncRNAs and were screened with the fold difference(FC) ≥ 2 times and the P value of the t-test <0.05 as the screening conditions. Cluster analysis was performed on the expression levels of the screened lncRNAs in normal breast tissues and breast cancer tissues. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes(KEGG) signaling pathway analysis were used to obtain the biological pathways involved in lncRNAs. Results Compared with the adjacent tissues, breast cancer tissues had 1 150 lncRNAs with more than 2 fold(|log2FC|> 1) differences. 551 lncRNAs were up-regulated and 599 were down-regulated. The most significant difference in down-regulated lncRNA was XR_159043.1(FC=26.878, P<0.05), and the most significant difference in up-regulated lncRNA was ENST00000427451.1(FC=11.478, P<0.05). It was found, through GO enrichment, that lncRNA was widely involved various biological processes including RNA processing, DNA splicing, gene expression, nucleobase-containing compound metabolic processes, and nucleic acid transport mRNA splicing were described. Through KEGG signal pathway enrichment analysis, it was found that lncRNA participates in PI3K-AKT and RIG-I-like receptor signaling pathways, and participates in transcriptional viral infections and estrogen signaling pathways in cancer. There were 119 target genes in differentially expressed lncRNA. Conclusion This study complements breast cancer-related lncRNA profiles, discovers a certain number of differentially expressed lncRNAs, and it predicts functionally targeted genes and pathways, which are expected to provide new approach for targeted therapy and prognostic evaluation for pancreatic cancer.
[1]李美珠,吴佳毅,朱丽.保乳手术切缘评估及术中乳腺X线摄片的临床应用[J].外科理论与实践,2020,25(6):537-540.
[2] BRAY F, FERLAY J, SOERJOMATARAM I, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2018,68(6):394-424.
[3]王峰,刘杰,曲根宝,等.多种血清肿瘤标志物联合检测在乳腺癌诊断中的意义[J].标记免疫分析与临床,2021,28(5):753-755,804.
[4]邱立阳.血清肿瘤标志物联合细胞因子检测在乳腺癌诊断中的应用价值[J].临床合理用药杂志,2021,14(3):167-168.
[5]何丽丽,曹国磊,马荣辉,等.调控网络分析肺栓塞患者外周血中lncRNAs、miRNAs和mRNAs的差异表达[J].新疆医科大学学报,2022,45(1):1-7.
[6] LIU Y,SHARMA S,WATABE K.Roles of lncRNA in breast cancer[J].Front Biosci(Schol Ed),2015,7:94-108.
[7] JARROUX J,MORILLON A,PINSKAYA M.History, discovery, and classification of lncRNAs[J].Adv Exp Med Biol,2017,1008:1-46.
[8]靳雪芹.长链非编码RNA与肿瘤研究进展[J].国际检验医学杂志,2018,39(12):1492-1495.
[9]潘亚芳,丛辉.长链非编码RNA H19在肿瘤中作用机制的研究进展[J].临床检验杂志,2017,35(3):209-211.
[10]成松桃,陈亮,王行环.基因芯片筛选肌浸润性膀胱癌分子标志物[J].现代泌尿外科杂志,2017,22(12):915-920.
[11]孙亚冬,王家祥,崔树德.基于SELDI-TOF-MS技术筛选乳腺癌血清蛋白标志物[J].中国实验诊断学,2019,23(9):1512-1517.
[12]万波,廖世奇,袁红霞,等.长链非编码RNA与肿瘤和干细胞[J].生物技术通报, 2015,31(7):39-45.
[13]陈继德.肝癌组织中长链非编码RNA SNHG3的表达及临床意义[J].检验医学与临床,2022,19(3):361-363,366.
[14]霍超,方学红,蒋代顺,等.长链非编码RNA在结直肠癌诊断及预后中的研究进展[J].临床与病理杂志,2022,42(1):203-208.
[15]姜丽娜,祁川川,陈艳丽,等.长链非编码RNA GAS5对乳腺癌细胞增殖、周期和凋亡的影响及其机制[J].中华实验外科杂志,2022,39(02):261-264.
[16]徐晓丽,林娟,鄢仁祥.基因芯片与高通量测序技术的原理与应用的比较[J].中国生物化学与分子生物学报,2018,34(11):36-44.
[17] IBRAHIM S, LAN C, CHABOT C, et al. Precise quantitation of PTEN by immuno-MRM:a tool to resolve the breast cancer biomarker controversy[J].Anal Chem,2021,93(31):10816-10824.
[18] WANG J,XIE S,YANG J,et al.The long noncoding RNA H19 promotes tamoxifen resistance in breast cancer via autophagy[J].J Hematol Oncol,2019,12(1):81.
[19] COLLETTE J,LE BOURHIS X,ADRIAENSSENS E.Regulation of human breast cancer by the long non-coding RNA H19[J]. Int J Mol Sci,2017,8(11):2319.
[20] PAW?OWSKA E,SZCZEPANSKA J,BLASIAK J.The long noncoding RNA HOTAIR in breast cancer:Does autophagy play a role?[J].Int J Mol Sci,2017,18(11):2317.
[21] JADALIHA M,ZONG X,MALAKAR P,et al. Functional and prognostic significance of long non-coding RNA MALAT1 as a metastasis driver in ER negative lymph node negative breast cancer[J].Oncotarget,2016,7(26):40418-40436.
基本信息:
中图分类号:R737.9
引用信息:
[1]赵倩,吐鲁洪·沙列尔.乳腺癌差异表达长链非编码RNA的筛选与分析[J].新疆医科大学学报,2022,45(03):238-243.
基金信息:
新疆维吾尔自治区自然科学基金(2017D01C379)
2021-09-23
2021
2021-12-21
2022-03-21
2022
1
2022-03-15
2022-03-15